fda compounding semaglutide crackdown october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Hims & Hers stock falls

For peptides like semaglutide, the primary temperature-dependent degradation pathways include deamidation, where asparagine and glutamine residues lose their amide groups, and peptide bond hydrolysis, where the backbone of the molecule literally breaks apart

arginine and proline metabolism, cardiolipin biosynthesis, de novo triacylglycerol biosynthesis, glutamate metabolism, creatine deficiency, guanidinoacetate methyltransferase deficiency

However, the agency also warns that trying to lose weight with an unapproved GLP-1 drug can be risky for patients. Others have raised concerns regarding the safety of compounded weight-loss drugs, which can cost hundreds of dollars less than FDA-approved treatments

MEDVis program framework begins with a comprehensive medical screening process to determine eligibility

The cochlear micro-circulation vessels (approximately diameters of 9.1 0.8 m) were in the downstream of the aforementioned resistance-sized arteries [60] so that the formation of micro-platelet-erythrocyte clots in the upstream would result in occlusion in the downstream vessels

Belle does not accept insurance for any treatment, including branded Wegovy and Zepbound